Assessment of the mutagenic, recombinogenic, and carcinogenic potential of amphotericin B in somatic cells of Drosophila melanogaster

References

• Alsaadi M, Italia JL, Mullen AB, et al. (2012). The efficacy of aerosol treatment with non-ionic surfactant vesicles containing amphotericin in rodent models of leishmaniasis and pulmonary aspergillosis infection. J Control Release 160:685–691.
   PubMed Web of Science ®Google Scholar
• Andrade HHR, Lehmann M. (2003). Teste para detecção de mutação e recombinação somática em Drosophila melanogaster. In: Ribeiro LR, Salvadori DMF, Marques EK, eds. Mutagênese ambiental. Canoas: Ulbra, 281–307.
   Google Scholar
• Arossi GA, Dih RR, Lehmann M, et al. (2009). In vivo genotoxicity of dental bonding agents. Mutagenesis 24:169–172.
   PubMed Web of Science ®Google Scholar
• Barrett JC. (1993). Mechanisms of multistep carcinogenesis and carcinogen risk assessment. Environ Health Perspect 100:9–12.
   PubMed Web of Science ®Google Scholar
• Casanova BB, Muniz MN, Oliveira T, et al. (2015). Synthesis and biological evaluation of hydrazone derivatives as antifungal agents. Molecules 20:9229–9241.
   PubMed Web of Science ®Google Scholar
• Castro AJS, Grisólia CK, Araújo BC, et al. (2008). Recombinogenic effects of the aqueous extract of pulp from pequi fruit (Caryocar brasiliense Camb) on somatic cells of Drosophila melanogaster. Genet Mol Biol 7:1375–1383.
   Google Scholar
• Costa WF, Nepomuceno JC. (2006). Protective effects of a mixture of antioxidant vitamins and minerals on the genotoxicity of doxorubicin in somatic cells of Drosophila melanogaster. Environ Mol Mutagen 47:18–24.
   PubMed Web of Science ®Google Scholar
• Costa WF, Oliveira AB, Nepomuceno JC. (2011). Lapachol as an epithelial tumor inhibitor agent in Drosophila melanogaster heterozygote for tumor suppressor gene wts. Genet Mol Res 10:3236–3245.
   PubMed Web of Science ®Google Scholar
• Cuenca P, Ramírez V. (2004). Mutagénesis ambiental y el uso de biomarcadores para predecir el riesgo de cancer. Rev Biol Trop 52:585–590.
   PubMed Web of Science ®Google Scholar
• Dutra ES, Dias CD, Araújo BC, et al. (2009). Effect of organic tomato (Lycopersicon esculentum) extract on the genotoxicity of doxorubicin in the Drosophila wing spot test. Genet Mol Biol 32:133–137.
   PubMed Web of Science ®Google Scholar
• Eeken JCJ, Klink I, Veen BLV, Ferro W. (2002). Induction of epithelial tumors in Drosophila melanogaster heterozygous for the tumor suppressor gene wts. Environ Mol Mutagen 40:277–282.
   PubMed Web of Science ®Google Scholar
• Egito LC, Medeiros SR, Medeiros MG, et al. (2004). Evaluation of the relationship of the molecular aggregation state of amphotericin B in medium to its genotoxic potential. J Pharm Sci 93:1557–1565.
   PubMed Web of Science ®Google Scholar
• Fauvel M, Farrugia C, Tsapis N, et al. (2012). Aerosolized liposomal amphotericin B: prediction of lung deposition, in-vitro uptake and cytotoxicity. Int J Pharm 435:106–110.
   Web of Science ®Google Scholar
• Fragiorge EJ, Spanó MA, Antunes LMG. (2007). Modulatory effects of the antioxidant ascorbic acid on the direct genotoxicity of doxorubicin in somatic cells of Drosophila melanogaster. Genet Mol Biol 30:449–455.
   Web of Science ®Google Scholar
• Frei H, Clements J, Howe D, Würgler FE. (1992). The genotoxicity of the anti-cancer drug mitoxantrone in somatic and germ cells of Drosophila melanogaster. Mutat Res 279:21–33.
   PubMed Web of Science ®Google Scholar
• Frei H, Würgler FE. (1988). Statistical methods to decide whether mutagenicity test data from Drosophila assays indicate a positive, negative, or inconclusive result. Mutat Res 203:297–308.
   PubMed Web of Science ®Google Scholar
• Frei H, Würgler FE. (1995). Optimal experimental design and sample size for the statistical evaluation of data from somatic mutation and recombination tests (SMART) in Drosophila. Mutat Res 334:247–258.
   PubMed Web of Science ®Google Scholar
• Frölich A, Würgler FE. (1989). New tester strains with improved bioactivation capacity for the Drosophila wing spot test. Mutat Res 216:179–187.
   PubMed Web of Science ®Google Scholar
• Graf U, Frei H, Kägi A, et al. (1989). Thirty compounds tested in the Drosophila wing spot test. Mutat Res 222:359–373.
   PubMed Web of Science ®Google Scholar
• Graf U, van Schaik N. (1992). Improved high bioactivation cross for the wing somatic and recombination test in Drosophila melanogaster. Mutat Res 271:59–67.
   PubMed Web of Science ®Google Scholar
• Graf U, Würgler FE, Katz AJ, et al. (1984). Somatic mutation and recombination test in Drosophila melanogaster. Environ Mutagen 6:153–188.
   PubMedGoogle Scholar
• Guzmán-Ricon J, Graf U. (1995). Drosophila melanogaster somatic mutation and recombination test as a biomonitor. In: Butterworth FM, et al., eds. Biomonitors and biomarkers: a indicators of environmental change, Vol. 402. New York: Plenum Press, 169–181.
   Google Scholar
• Hallström I, Blank A. (1985). Genetic regulation of the cytochrome P-450 – dependent reactions. Chem Biol Interact 31:157–171.
   Web of Science ®Google Scholar
• Im C, Waskell L. (2011). The interaction of microsomal cytochrome P450 2B4 with its redox partners, cytochrome P450 reductase and cytochrome b5. Arch Biochem Biophys 1:144–153.
   Web of Science ®Google Scholar
• Justice RW, Zilian O, Woods DF, et al. (1995). The Drosophila tumor suppressor gene warts encodes a homolog of human myotonic dystrophy kinase and is required for the control of cell shape and proliferation. Genes Dev 9:534–546.
   PubMed Web of Science ®Google Scholar
• Kastenbaum MA, Bowman KO. (1970). Tables for determining the statistical significance of mutation frequencies. Mutat Res 9:527–549.
   PubMed Web of Science ®Google Scholar
• Kim JH, Chan KL, Faria NCG, et al. (2012). Targeting the oxidative stress response system of fungi with safe, redox-potent chemosensitizing agents. Front Microbiol 3:88.
   PubMed Web of Science ®Google Scholar
• Kim JH, Mahoney N, Chan KL, Campbell BC. (2011). Antifungal activity of redox-active benzaldehydes that target cellular antioxidation. Ann Clin Microbiol Antimicrob 10:1–16.
   PubMed Web of Science ®Google Scholar
• Knoderer CA, Knoderer HM. (2011). Hyperphosphatemia in pediatric oncology patients receiving liposomal amphotericin B. J Pediatr Pharmacol Ther 16:87–91.
   PubMedGoogle Scholar
• Lehmann M, Franco A, Vilar KSP, et al. (2003). Doxorubicin and two of its analogues are preferential inducers of homologous recombination compared with mutational events in somatic cells of Drosophila melanogaster. Mutat Res 539:167–175.
   PubMed Web of Science ®Google Scholar
• Lindsley DL, Zimm GG. (1992). The genome of Drosophila melanogaster. San Diego, CA: Academic Press, 1133.
   Google Scholar
• Machado NM, Lopes JC, Saturnino RS, et al. (2013). Lack of mutagenic effect by multi-walled functionalized carbon nanotubes in the somatic cells of Drosophila melanogaster. Food Chem Toxicol 62:355–360.
   PubMed Web of Science ®Google Scholar
• Maher VM, Bhattacharyya NP, Mah MC, et al. (1993). Mutations induced by 1-nitrosopyrene and related compounds during DNA replication in human cells and induction of homologous recombination by these compounds. Res Rep Health Eff Inst 40:41–51.
   Google Scholar
• Manzoni P, Galletto S, Franco C, et al. (2012). Liposomal amphotericin B does not induce nephrotoxicity or renal function impairment in premature neonates. Early Human Dev 88:86–91.
   PubMed Web of Science ®Google Scholar
• Miceli MH, Chandrasekar P. (2012). Safety and efficacy of liposomal amphotericin B for the empirical therapy of invasive fungal infections in immunocompromised patients. Infect Drug Resist 5:9–16.
   PubMedGoogle Scholar
• Nakamura R, Kondo R, Shen MH, et al. (2012). Identification of cytochrome P450 monooxygenase genes from the white-rot fungus Phlebia brevispora. AMB Express 2:8–8.
   PubMed Web of Science ®Google Scholar
• Nishiyama Y, Hirota T, Morisaki T, et al. (1999). A human homolog of Drosophila warts tumor suppressor, h-warts, localized to mitotic apparatus and specifically phosphorylated during mitosis. FEBS Lett 459:159–165.
   PubMed Web of Science ®Google Scholar
• Nowell P. (1976). The clonal evolution of tumor cell populations. Science 194:23–28.
   PubMed Web of Science ®Google Scholar
• Ogita A, Fujita KI, Tanaka T. (2012). Enhancing effects on vacuole-targeting fungicidal activity of amphotericin B. Front Microbiol 100:1–6.
   Google Scholar
• Oliveira LFS, Fuentefria AM, Klein FS, Machado MM. (2014). Antifungal activity against Cryptococcus neoformans strains and genotoxicity assessment in human leukocyte cells of Euphorbia tirucalli L. Brazilian J Microbiol 45:1349–1355.
   PubMed Web of Science ®Google Scholar
• Orsolin PC, Silva-Oliveira RG, Nepomuceno JC. (2012). Assessment of the mutagenic, recombinogenic and carcinogenic potential of orlistat in somatic cells of Drosophila melanogaster. Food Chem Toxicol 50:2598–2604.
   PubMed Web of Science ®Google Scholar
• Oshima-Franco Y, Franco LM. (2003). Biotransformação: importância e toxicidade. Rev Saúde Piracicaba 5:69–76.
   Google Scholar
• Peixoto DLG. (2009). Avaliação da biocompatibilidade da anfotericina b em duas formulações: livre e associada com nanopartículas magnéticas. Dissertação de Mestrado em Patologia Molecular. Universidade de Brasília.
   Google Scholar
• Pereira DG, Antunes LMG, Graf U, Spanó MA. (2008). Protection by Panax ginseng C. A. Meyer against the genotoxicity of doxorubicin in somatic cells of Drosophila melanogaster. Genet Mol Biol 31:947–955.
   Web of Science ®Google Scholar
• Rezende AAD, Graf U, Guterres ZR, et al. (2009). Protective effects of proanthocyanidins of grape (Vitis vinifera L.) seeds on DNA damage induced by doxorubicin in somatic cells of Drosophila melanogaster. Food Chem Toxicol 47:1466–1472.
   PubMed Web of Science ®Google Scholar
• Sengstag C. (1994). The role of mitotic recombination in carcinogenesis. Crit Rev Toxicol 24:323–353.
   PubMed Web of Science ®Google Scholar
• Sinigaglia M, Reguly ML, de Andrade HH. (2004). Effect of vanillin on toxicant induced mutation and mitotic recombination in proliferating somatic cells of Drosophila melanogaster. Environ Mol Mutagen 44:394–400.
   PubMed Web of Science ®Google Scholar
• Sivak O, Gershkovich P, Lin M, et al. (2011). Tropically stable novel oral lipid formulation of amphotericin B (iCo-010): biodistribution and toxicity in a mouse model. Lipids Health Dis 10:135–5.
   PubMed Web of Science ®Google Scholar
• Suschek CV, Bonmann E, Kleinert H, et al. (2000). Amphotericin B severely affects expression and activity of the endothelial constitutive nitric oxide synthase involving altered mRNA stability. Br J Pharmacol 131:473–481.
   PubMed Web of Science ®Google Scholar
• van de Ven H, Paulussen C, Feijens PB, et al. (2012). PLGA nanoparticles and nanosuspensions with amphotericin B: potent in vitro and in vivo alternatives to Fungizone and AmBisome. J Control Release 161:795–803.
   PubMed Web of Science ®Google Scholar
• Virág E, Belagyi J, Gazdag Z, et al. (2012). Direct in vivo interaction of the antibiotic primycin with the plasma membrane of Candida albicans: an EPR study. Biochim Biophys Acta 1818:42–48.
   PubMed Web of Science ®Google Scholar